Unlimited Bio

First preventive gene therapy
for increasing tissue capillarisation
coming in 2024
Unlimited Bio
First preventive gene therapy for increasing tissue capillarisation coming in 2024

Unlimited Bio
First preventive gene therapy for increasing tissue capillarisation coming soon

Our goal is to conduct 100 clinical trials of genetic therapies and their combinations in 10 years by making use of the regulatory flexibility of Próspera ZEDE (Roatan, Honduras).
VEGF is a safe and effective gene therapy with a long history of use for PAD
Backed up by a multitude of papers and studies on humans: 1,2,3,4.
Unlimited Bio brings new VEGF Indications to Roatan
Team
  • Ivan Morgunov
    CEO
  • Anna Vakhrusheva, PhD
    CTO
  • Vladimir Leshko
    COO
  • Olga Borysova
    Scientific Analyst
  • Anastasia Bakulina
    Scientific Analyst
  • Adam Gries
    Advisor
  • Tristan Roberts
    Advisor
  • Aleksandr Fedintsev
    Advisor
  • Gustavo Vera Janavel, MD
    Advisor
Team
  • Ivan Morgunov
    CEO
  • Anna Vakhrusheva, PhD
    CTO
  • Vladimir Leshko
    COO
  • Olga Borysova
    Scientific Analyst
  • Anastasia Bakulina
    Scientific Analyst
  • Adam Gries
    Advisor
  • Tristan Roberts
    Advisor
  • Aleksandr Fedintsev
    Advisor
  • Gustavo Vera Janavel, MD
    Advisor
Are you a longevity-minded MD?

Do you run a longevity clinic?

Want to partner with us?

Reach out.
partners@unlimit.bio
Are you a longevity-minded MD?

Do you run a longevity clinic?

Want to partner with us?

Reach out.
partners@unlimit.bio
Made on
Tilda